Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. [electronic resource]
Producer: 20010705Description: 3103-10 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Belgium -- epidemiology
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant -- methods
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Methotrexate -- administration & dosage
- Middle Aged
- Prognosis
- Proportional Hazards Models
- Statistics, Nonparametric
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.